Company Focus

Teva Pharmaceutical Industries

Latest Teva Pharmaceutical Industries News

Teva points to long-term efficacy of Ajovy in migraine
Biotechnology
Israel’s Teva Pharmaceutical Industries has announced that the final analysis of the pan-European PEARL Phase IV migraine prevention study showed that Ajovy (fremanezumab), an anti-calcitonin gene-related peptide (CGRP) monoclonal antibody, delivered sustained effectiveness over a two-year period in cutting frequency, duration and severity of attacks in chronic and episodic migraine.   25 June 2025


Latest News & Features of interest to Teva Pharmaceutical Industries

Latest In Brief for Teva Pharmaceutical Industries

Pharmaceutical
Ireland-based biopharma Jazz Pharmaceuticals has been called out for a couple of indiscretions by The Prescription Medicines Code of Practice Authority (PMCPA), which was established by the Association of the British Pharmaceutical Industry (ABPI) to operate the ABPI Code of Practice for the Pharmaceutical Industry.   11 July 2025

Latest Relevant Ones To Watch News


More in M&A >


Relevant Ones to Watch Companies

Reset all filters
Refine Search